AI-Enhanced Optimization of Acute Levodopa Challenge Test
Studying Classic progressive supranuclear palsy syndrome
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Beijing Tiantan Hospital
- Intervention
- video recording(other)
- Enrollment
- 2000 enrolled
- Eligibility
- 50-75 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- Beijing Tiantan Hospital, Affiliated to Capital Medical University, Beijing, China
Collaborators
Ruijin Hospital · Nanjing Medical University · Second Affiliated Hospital of Soochow University · Beijing Hospital · Fujian Medical University Union Hospital · Guangdong Provincial People's Hospital · West China Hospital · The First Affiliated Hospital of Dalian Medical University · China-Japan Union Hospital, Jilin University · Renmin Hospital of Wuhan University · First Affiliated Hospital of Chongqing Medical University · Second Affiliated Hospital of Nanchang University · Xijing Hospital · The Affiliated Hospital of Qingdao University · The Second Affiliated Hospital of Xinjiang Medical University · Shenzhen People's Hospital · Tianjin Medical University General Hospital · Qilu Hospital of Shandong University · The First People's Hospital of Yunnan · The First Hospital of Jilin University · Tianjin Huanhu Hospital · The First Affiliated Hospital of Anhui Medical University · Wannan Medical College Yijishan Hospital · The Affiliated Hospital of Xuzhou Medical University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06949865 on ClinicalTrials.govOther trials for Classic progressive supranuclear palsy syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07509125Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic DisordersUniversitaire Ziekenhuizen KU Leuven
- RECRUITINGEARLY PHASE1NCT07348276First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the BrainInvicro
- RECRUITINGNANCT07291687tDCS as Treatment for Motor FunctionBaycrest
- ACTIVE NOT RECRUITINGNANCT06588673Art Therapy in Progressive Supranuclear PalsyVanderbilt University Medical Center
- ENROLLING BY INVITATIONNANCT06597071Parkinson Atypical Rating of Oculometric Patterns Evaluated RoutinelyNeuraLight
- ACTIVE NOT RECRUITINGPHASE2NCT06355531A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)Ferrer Internacional S.A.
- RECRUITINGNANCT06174948The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related DisordersQueen Mary University of London
- RECRUITINGNCT06529744Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative ModelingUniversity Health Network, Toronto
See all trials for Classic progressive supranuclear palsy syndrome →